Nexalin Technology, Inc. (NXL)

NASDAQ: NXL · Real-Time Price · USD

0.3245

-0.0180 (-5.26%)

At close: May 18, 2026, 4:00 PM EDT

0.3300

+0.0055 (1.69%)

After-hours: May 18, 2026, 4:53 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Medical Products	301.65K	168.72K	110.75K	1.32M	144.07K
Medical Products Growth	78.78%	52.35%	-91.62%	817.20%	-40.69%
Total	301.65K	168.72K	110.75K	1.32M	144.07K
Total Growth	78.78%	52.35%	-91.62%	817.20%	-40.69%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States	111.35K	83.47K	107.13K	113.54K	117.93K
United States Growth	33.39%	-22.09%	-5.64%	-3.72%	-51.45%
China	190.30K	85.25K	3.61K	1.21M	26.13K
China Growth	123.23%	2258.83%	-99.70%	4521.98%	-
Total	301.65K	168.72K	110.75K	1.32M	144.07K
Total Growth	78.78%	52.35%	-91.62%	817.20%	-40.69%

Source: S&P Global Market Intelligence.